Koji Furuuchi

484 total citations
41 papers, 270 citations indexed

About

Koji Furuuchi is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Koji Furuuchi has authored 41 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Epidemiology, 24 papers in Infectious Diseases and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Koji Furuuchi's work include Mycobacterium research and diagnosis (32 papers), Tuberculosis Research and Epidemiology (18 papers) and Infectious Diseases and Mycology (13 papers). Koji Furuuchi is often cited by papers focused on Mycobacterium research and diagnosis (32 papers), Tuberculosis Research and Epidemiology (18 papers) and Infectious Diseases and Mycology (13 papers). Koji Furuuchi collaborates with scholars based in Japan, United States and Israel. Koji Furuuchi's co-authors include Kozo Morimoto, Keiji Fujiwara, Ken Ohta, Tadashi Ishida, Shogo Kumagai, Akihiro Ito, Atsuyuki Kurashima, Yoshiaki Tanaka, Kozo Yoshimori and Takashi Yoshiyama and has published in prestigious journals such as Clinical Infectious Diseases, Scientific Reports and CHEST Journal.

In The Last Decade

Koji Furuuchi

35 papers receiving 269 citations

Peers

Koji Furuuchi

EPIDE

PRM

SURGE

Sarah Bendien Netherlands

Reginald J. Claypool United States

Hongfei Duan China

Ichizo Suemitsu Japan

Karsten Kötz Sweden

Gill Han Bai South Korea

M. Santos Spain

Can Biçmen Türkiye

Keita Takeda Japan

Ashley B. Wentworth United States

Sarah Bendien Netherlands

Koji Furuuchi

232 ×1.0

EPIDE

160 ×0.9

133 ×1.4

52 ×0.9

PRM

34 ×0.9

SURGE

Citations per year, relative to Koji Furuuchi Koji Furuuchi (= 1×) peers Sarah Bendien

Countries citing papers authored by Koji Furuuchi

Since Specialization

Citations

This map shows the geographic impact of Koji Furuuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koji Furuuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koji Furuuchi more than expected).

Fields of papers citing papers by Koji Furuuchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koji Furuuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koji Furuuchi. The network helps show where Koji Furuuchi may publish in the future.

Co-authorship network of co-authors of Koji Furuuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Koji Furuuchi. A scholar is included among the top collaborators of Koji Furuuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koji Furuuchi. Koji Furuuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kodama, Tatsuya, Akio Aono, Keiji Fujiwara, et al.. (2025). Risk factors, molecular analysis and treatment outcomes of amikacin-resistant Mycobacterium avium complex pulmonary disease. ERJ Open Research. 11(4). 1084–2024.

Ito, Masashi, Koji Furuuchi, Keiji Fujiwara, et al.. (2024). Epidemiological trends and clinical relevance of nontuberculous mycobacterial pulmonary disease in a referral hospital in Japan, 2017–2021. Respiratory Investigation. 62(6). 1064–1071.

Fujiwara, Keiji, Koji Furuuchi, Masashi Ito, et al.. (2024). Beyond Symptoms: Radiologic identification of asymptomatic Mycobacterium avium complex pulmonary infections. Respiratory Medicine. 226. 107627–107627. 2 indexed citations

Ito, Masashi, Koji Furuuchi, Keiji Fujiwara, et al.. (2024). Quantifying the Reversibility of Clofazimine-induced Pigmentation in a Patient with <i>Mycobacterium abscessus</i> Pulmonary Disease. Internal Medicine. 64(12). 1884–1887.

Ito, Masashi, Koji Furuuchi, Keiji Fujiwara, et al.. (2023). Multiple bacterial culture positivity reflects the severity and prognosis as bronchiectasis in Mycobacterium avium complex pulmonary disease. Respiratory Medicine. 219. 107417–107417. 3 indexed citations

Osawa, Takeshi, Masato Watanabe, Kozo Morimoto, et al.. (2023). Activities of Daily Living, Hypoxemia, and Lymphocytes Score for Predicting Mortality Risk in Patients With Pulmonary TB. CHEST Journal. 165(2). 267–277. 4 indexed citations

Morimoto, Kozo, Kazuro Iwai, Takashi Yoshiyama, et al.. (2022). Epidemiological characteristics of nontuberculous mycobacteriosis and bronchiectasis: comparative study using national mortality statistics from 1970 to 2015 in Japan. ERJ Open Research. 9(1). 424–2022. 4 indexed citations

Fujiwara, Keiji, Mitsunori Yoshida, Yoshiro Murase, et al.. (2022). Potential Cross-Transmission of Mycobacterium abscessus among Non-Cystic Fibrosis Patients at a Tertiary Hospital in Japan. Microbiology Spectrum. 10(3). e0009722–e0009722. 17 indexed citations

Furuuchi, Koji, Keiji Fujiwara, Yoshiaki Tanaka, et al.. (2022). Low-dosage ethambutol, less than 12.5 mg/kg/day, does not worsen the clinical outcomes of pulmonary Mycobacterium avium and Mycobacterium intracellulare disease: a retrospective cohort study. Infection. 50(4). 879–887. 2 indexed citations

10.

Shimoda, Masafumi, Takashi Yoshiyama, Masao Okumura, et al.. (2022). Analysis of risk factors for pulmonary tuberculosis with persistent severe inflammation. Medicine. 101(19). e29297–e29297. 3 indexed citations

11.

Shimoda, Masafumi, Yoshiaki Tanaka, Keiji Fujiwara, et al.. (2021). Waterproofing spray-associated pneumonitis review. Medicine. 100(10). e25054–e25054. 2 indexed citations

12.

Shimoda, Masafumi, Yoshiaki Tanaka, Koji Furuuchi, et al.. (2021). Actinomyces meyeri pleural infection that was difficult to treat due to delayed culture: A case report and literature review of 28 cases. Respiratory Medicine Case Reports. 34. 101530–101530. 3 indexed citations

13.

Shirai, Tatsuya, Koji Furuuchi, Keiji Fujiwara, et al.. (2020). Impact of Aspergillus precipitating antibody test results on clinical outcomes of patients with Mycobacterium avium complex lung disease. Respiratory Medicine. 166. 105955–105955. 8 indexed citations

14.

Furuuchi, Koji, Kozo Morimoto, Atsuyuki Kurashima, et al.. (2020). Treatment Duration and Disease Recurrence Following the Successful Treatment of Patients With Mycobacterium avium Complex Lung Disease. CHEST Journal. 157(6). 1442–1445. 11 indexed citations

15.

Fujiwara, Keiji, Koji Furuuchi, Akio Aono, et al.. (2020). Mycobacterium europaeum lung disease in an immunocompetent patient without underlying lung disease. Journal of Infection and Chemotherapy. 27(1). 107–109. 3 indexed citations

16.

Matsuda, Shuichi, Takanori Asakura, Kozo Morimoto, et al.. (2020). Clinical significance of anti-glycopeptidolipid-core IgA antibodies in patients newly diagnosed with Mycobacterium avium complex lung disease. Respiratory Medicine. 171. 106086–106086. 7 indexed citations

17.

Nakamoto, Keitaro, Yuka Sasaki, Tatsuya Shirai, et al.. (2019). ABSTRACT WITHDRAWN. Respirology. 24(S2). 21–21.

18.

Furuuchi, Koji, Kozo Morimoto, Takashi Yoshiyama, et al.. (2019). Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan. Respiratory Medicine. 152. 74–80. 57 indexed citations

19.

Furuuchi, Koji, Akihiro Ito, Toru Hashimoto, Shogo Kumagai, & Tadashi Ishida. (2018). Risk stratification for the development of chronic pulmonary aspergillosis in patients with Mycobacterium avium complex lung disease. Journal of Infection and Chemotherapy. 24(8). 654–659. 13 indexed citations

20.

Furuuchi, Koji, Akihiro Nishiyama, Hiroshige Yoshioka, Toshihide Yokoyama, & Tadashi Ishida. (2016). Reenlargement of radiation necrosis after stereotactic radiotherapy for brain metastasis from lung cancer during bevacizumab treatment. Respiratory Investigation. 55(2). 184–187. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact